TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 24)
2.1 RESEARCH APPROACH
2.2 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key data from primary source
2.2.2.2 Breakdown of primary interviews: by company type, designation, and region
2.2.2.3 Key industry insights
2.3 MARKET SIZE ESTIMATION
2.3.1 TOP-DOWN APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 DATA TRIANGULATION APPROACH
2.5 MARKET SHARE ESTIMATION
2.5.1 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. – 34)

4 PREMUIM INSIGHTS (Page No. – 39)
4.1 MEDICAL SIMULATION MARKET OVERVIEW
4.2 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCTS & SERVICES AND COUNTRY (2019)
4.3 MEDICAL SIMULATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: MEDICAL SIMULATION MARKET
4.5 MEDICAL SIMULATION MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW (Page No. – 44)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Limited access to live patients during training
5.2.1.2 Advancements in medical education
5.2.1.3 Growing demand for minimally invasive treatments
5.2.1.4 Increasing focus on patient safety
5.2.1.5 Increasing demand for virtual training due to the current COVID-19 pandemic
5.2.2 RESTRAINTS
5.2.2.1 Limited availability of funds
5.2.2.2 Incomplete mimicking of the medical simulators
5.2.3 OPPORTUNITIES
5.2.3.1 Shortage of healthcare personnel
5.2.3.2 Growing awareness regarding simulation education in emerging countries
5.2.4 CHALLENGES
5.2.4.1 High cost of simulators
5.2.4.2 Operational challenges

6 INDUSTRY INSIGHTS (Page No. – 52)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 USE OF VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR) IN MEDICAL SIMULATION
6.2.2 RACE TOWARDS TOP FIDELITY
6.2.3 USE OF MULTIDISCIPLINARY APPROACH IN THE DEVELOPMENT OF SIMULATORS
6.2.4 ARTIFICIAL INTELLIGENCE USED IN SURGERY BACKED UP WITH SOFTWARE
6.2.5 HCIT/EMR

7 GLOBAL MEDICAL SIMULATION MARKET, BY PRODUCTS & SERVICES (Page No. – 55)
7.1 INTRODUCTION
7.2 MEDICAL SIMULATION ANATOMICAL MODELS
7.2.1 PATIENT SIMULATORS
7.2.1.1 High Fidelity Simulators
7.2.1.2 Medium Fidelity Simulators
7.2.1.3 Low Fidelity Simulators
7.2.2 TASK TRAINERS
7.2.2.1 Inability of task trainers to imitate the emotional attributes of patients is expected to hamper the growth of the segment to an extent
7.2.3 INTERVENTIONAL/SURGICAL SIMULATORS
7.2.3.1 Laparoscopic Surgical Simulators
7.2.3.2 Gynecology Simulators
7.2.3.3 Cardiovascular Simulators
7.2.3.4 Orthopedic Surgical Simulators
7.2.3.5 Spine Surgical Simulators
7.2.3.6 Other Interventional/Surgical Simulators
7.2.4 ENDOVASCULAR SIMULATORS
7.2.4.1 Endovascular simulators help in reducing mortality rates and offer shorter recovery periods for patients as compared to vascular procedures
7.2.5 ULTRASOUND SIMULATORS
7.2.5.1 Poor quality of image from low dynamics, spatial resolution and signal to noise ratio are major challenges in the growth of the segment
7.2.6 DENTAL SIMULATORS
7.2.6.1 Expanding dental tourism industry is fueling the demand for dental simulators
7.2.7 EYE SIMULATORS
7.2.7.1 Increasing incidence of eye disorders across the globe due to the rapidly growing geriatric population to drive the growth of the segment
7.3 WEB-BASED SIMULATION
7.4 MEDICAL SIMULATION SOFTWARE
7.4.1 PERFORMANCE RECORDING SOFTWARE
7.4.1.1 Complexity, compromised system integration, and time constraints due to manual processes to restrain the growth of this market
7.4.2 VIRTUAL TUTORS
7.4.2.1 Virtual reality is helping to reduce human errors in the medical sector
7.5 SIMULATION TRAINING SERVICES
7.5.1 VENDOR-BASED TRAINING
7.5.1.1 High focus on patient safety in actual clinical practices to propel the growth of this market
7.5.2 EDUCATIONAL SOCIETIES
7.5.2.1 Need for proper training and authenticated knowledge is driving the growth of this market
7.5.3 CUSTOM CONSULTING SERVICES
7.5.3.1 Urgent need to curtail the problems faced due to traditional medical training systems is propelling the growth of this market

8 GLOBAL MEDICAL SIMULATION MARKET, BY END USER (Page No. – 102)
8.1 INTRODUCTION
8.2 ACADEMIC INSTITUTES
8.2.1 GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO INCREASE THE USE OF MEDICAL SIMULATORSIN ACADEMIC INSTITUTIONS
8.3 HOSPITALS
8.3.1 INCREASING NUMBER OF COVID-19 PATIENTS AND RISING FOCUS ON MINIMIZING ERRORS ARE DRIVING THE GROWTH OF THE MEDICAL SIMULATION MARKET FOR HOSPITALS
8.4 MILITARY ORGANIZATIONS
8.4.1 INCREASE IN THE USE OF SIMULATORS TO EXPLORE NEW METHODS FOR OVERCOMNG WARFARE CONDITIONS IS PROPELLING THE GROWTH OF THIS MARKET.
8.5 OTHER END USERS

9 GLOBAL MEDICAL SIMULATION MARKET, BY GEOGRAPHY (Page No. – 110)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 Increasing demand for virtual tutors due to current COVID-19 pandemic among other factors, longer life expectancy and the baby boomer generation, resulting in higher healthcare spending.
9.2.2 CANADA
9.2.2.1 Increase in funding, surgical capacity, and number of treatment programs in some provinces of Canada, especially Ontario, to drive the growth of the market
9.3 UROPE
9.3.1 GERMANY
9.3.1.1 High healthcare spending to be key driver for market growth in Germany
9.3.2 FRANCE
9.3.2.1 Mandate to provide all surgical residents with simulation training in France to boost the market growth
9.3.3 UK
9.3.3.1 Increasing government healthcare expenditure and rising number of healthcare simulation centers and hospitals are fueling the growth of the medical simulation market in the UK
9.3.4 ITALY
9.3.4.1 Growing burden of several diseases and shortage of healthcare workforce are expected to increase the demand for simulation-based training
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.1.1 Increasing demand for virtual tutors, mannequins, and technologically advanced simulators is major reason for the growth of this market
9.4.2 CHINA
9.4.2.1 Simulated training can provide both medical students and patients a safe environment for practice and errors, which in turn will drive the market for medical simulation in China
9.4.3 INDIA
9.4.3.1 Growing awareness regarding patient safety issues among general public, and rising need to bridge the gap between requirement and opportunities for training
9.4.4 EST OF ASIA-PACIFIC (ROAPAC)
9.4.5 LATIN AMERICA
9.4.6 BRAZIL
9.4.6.1 High incidence of chronic diseases to drive the demand for medical simulation MARKET
9.4.7 MEXICO
9.4.7.1 disruptive technologies and private–public partnerships to evolve healthcare IN THE COUNTRY
9.4.8 REST OF LATIN AMERICA

10 COMPETITIVE LANDSCAPE (Page No. – 182)
10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS
10.2.1 CAE (CANADA)
10.2.2 3D SYSTEMS (US)
10.3 COMPETITIVE LEADERSHIP MAPPING, 2019
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 EMERGING COMPANIES
10.3.4 DYNAMIC DIFFERENTIATORS
10.4 COMPETITIVE SITUATIONS AND TRENDS
10.4.1 NEW PRODUCT LAUNCH
10.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
10.4.3 ACQUISITIONS

11 COMPANY PROFILES (Page No. – 189)
11.1 CAE INC.
11.1.1 BUSINESS OVERVIEW
11.1.2 PRODUCTS OFFERED
11.1.3 SERVICES OFFERED
11.1.4 RECENT DEVELOPMENTS
11.1.5 MNM VIEW
11.2 3D SYSTEMS
11.2.1 BUSINESS OVERVIEW
11.2.2 PRODUCTS OFFERED
11.2.3 SERVICES OFFERED
11.2.4 RECENT DEVELOPMENTS
11.2.5 MNM VIEW
11.3 1.3 LAERDAL MEDICAL
11.3.1 BUSINESS OVERVIEW
11.3.2 PRODUCTS OFFERED
11.3.3 SERVICES OFFERED
11.3.4 RECENT DEVELOPMENTS
11.3.5 MNM VIEW
11.4 GAUMARD SCIENTIFIC COMPANY
11.4.1 BUSINESS OVERVIEW
11.4.2 PRODUCTS OFFERED
11.4.3 SERVICES OFFERED
11.4.4 RECENT DEVELOPMENTS
11.4.5 MNM VIEW
11.5 KYOTO KAGAKU
11.5.1 BUSINESS OVERVIEW
11.5.2 PRODUCTS OFFERED
11.5.3 RECENT DEVELOPMENTS
11.5.4 MNM VIEW
11.6 LIMBS & THINGS
11.6.1 BUSINESS OVERVIEW
11.6.2 PRODUCTS OFFERED
11.6.3 RECENT DEVELOPMENTS
11.6.4 MNM VIEW
11.7 MENTICE AB
11.7.1 BUSINESS OVERVIEW
11.7.2 PRODUCTS OFFERED
11.7.3 SERVICES OFFERED
11.7.4 RECENT DEVELOPMENTS
11.7.5 MNM VIEW
11.8 SIMULAB CORPORATION
11.8.1 BUSINESS OVERVIEW
11.8.2 PRODUCTS OFFERED
11.8.3 SERVICES OFFERED
11.8.4 RECENT DEVELOPMENTS
11.8.5 MNM VIEW
11.9 SIMULAIDS
11.9.1 BUSINESS OVERVIEW
11.9.2 PRODUCTS OFFERED
11.9.3 SERVICES OFFERED
11.9.4 MNM VIEW
11.10 INTELLIGENT ULTRASOUND GROUP PLC
11.10.1 BUSINESS OVERVIEW
11.10.2 SOLUTIONS OFFERED
11.10.3 SERVICES OFFERED
11.10.4 RECENT DEVELOPMENTS
11.10.5 MNM VIEW
11.11 OPERATIVE EXPERIENCE, INC.
11.11.1 BUSINESS OVERVIEW
11.11.2 PRODUCTS OFFERED
11.11.3 RECENT DEVELOPMENTS
11.11.4 EXPANSION
11.12 SURGICAL SCIENCE SWEDEN AB.
11.12.1 BUSINESS OVERVIEW
11.12.2 PRODUCTS OFFERED
11.12.3 RECENT DEVELOPMENTS
11.13 CARDIONICS INC.
11.13.1 BUSINESS OVERVIEW
11.13.2 PRODUCTS OFFERED
11.13.3 RECENT DEVELOPMENTS
11.14 VIRTAMED AG
11.14.1 BUSINESS OVERVIEW
11.14.2 PRODUCTS OFFERED
11.14.3 RECENT DEVELOPMENTS
11.15 SYNBONE AG
11.15.1 BUSINESS OVERVIEW
11.15.2 PRODUCTS OFFERED
11.16 VRMAGIC HOLDING AG.
11.17 OSSIMTECH
11.18 HRV SIMULATION
11.19 SYNAPTIVE MEDICAL
11.20 INOVUS MEDICAL